C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
10/2011
10/26/2011	EP2380882A1 Salts of heterocyclic anions and their uses as ionic conductive materials
10/26/2011	EP2379534A1 Heterocyclic antiviral compounds
10/26/2011	EP2379519A1 (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives
10/26/2011	EP2379511A1 Substituted diketopiperazine analogs for use as drug delivery agents
10/26/2011	EP2379503A1 Heterocyclic diketone derivatives with herbicidal action
10/26/2011	EP2022786B1 Anti-foot-and-mouth disease virus agent for animal belonging to family suidae or sheep, and method for prevention or treatment of foot-and-mouth disease in animal belonging to family suidae or sheep
10/26/2011	CN102227486A Organic electroluminscent device using electroluminescent compounds
10/26/2011	CN102225913A Rheinic acid derivatives and treatment application thereof
10/26/2011	CN102225896A Ether derivatives of rhein and their therapeutic use
10/25/2011	US8044056 Adenine compound
10/25/2011	US8044053 Sulfonamide substituted pyrazoline compounds, their preparation and use as CB1 modulators
10/25/2011	US8044048 Derivatives of sulindac, use thereof and preparation thereof
10/20/2011	WO2011128989A1 Pyrazine-2-carboxamide derivative and fungicides containing same as active ingredient
10/20/2011	US20110257398 Compositions and Methods Including Cell Death Inducers and Procaspase Activation
10/20/2011	US20110257183 Bis-aryl sulfonamides
10/19/2011	EP2376495A2 Compositions of protein receptor tyrosine kinase inhibitors
10/19/2011	EP2376459A1 Modified pyrazine derivatives and uses thereof
10/19/2011	EP2376458A1 Modified pyrazine derivatives and uses thereof
10/19/2011	CN102224217A Electroluminescent device using the electroluminescent compounds
10/19/2011	CN102219784A Heteroaryl urea derivatives useful for inhibiting CHKl
10/18/2011	US8039623 Peptidomimetics compound; viricides; interference in life cycle og hepatitis c virus
10/18/2011	US8039471 Aza spiro alkane derivatives as inhibitors of metalloproteases
10/18/2011	CA2502717C Mixture of oligomeric phenazinium compounds and acid bath for electrolytically depositing a copper deposit
10/13/2011	WO2011124307A1 Fluorinating reagents with (perfluoralkyl) fluorophosphate anion
10/13/2011	US20110251389 Process For Making N-(Diphenylmethyl)piperazines
10/13/2011	US20110251209 Compounds for treating parasitic disease
10/13/2011	US20110251206 Squaramide derivatives as CXCR2 antagonist
10/13/2011	US20110251204 Modulators of G Protein-Coupled Receptor 88
10/13/2011	US20110251200 Aryl guanidine f1f0-atpase inhibitors and related methods
10/13/2011	US20110251196 Modulators of G Protein-Coupled Receptor 88
10/13/2011	US20110250140 Modified Pyrazine Derivatives and Uses Thereof
10/13/2011	US20110250139 Modified Pyrazine Derivatives and Uses Thereof
10/13/2011	US20110250135 Piperazine Derivatives for Binding and Imaging Amyloid Plaques and Their Use
10/12/2011	EP2374802A1 Kynurenine production inhibitor
10/12/2011	EP2373660A2 3,6-disubstituted xanthylium salts as medicaments
10/12/2011	CN102214805A Light-emitting element, light-emitting device, electronic device and quinoxaline derivative
10/12/2011	CN102212037A Synthesis method of phenazine-2,3-diamine hydrochloride
10/12/2011	CN102212036A Preparation method of N-(pyrazine-2-radical carbonyl)-L-phenyl alanine
10/12/2011	CN102212035A Preparation method for sulfamethoxypyrazine
10/12/2011	CN102212008A Tanshinol ligustrazine derivative and preparation method and application thereof
10/12/2011	CN101296909B Pyrazine derivatives and use as pI3K inhibitors
10/11/2011	US8034819 Glucokinase activator
10/11/2011	CA2578066C Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
10/06/2011	US20110245493 Delivery of drug amines through an inhalation route
10/06/2011	US20110245462 Non-Fluorescent Quencher Compounds and Biomolecular Assays
10/06/2011	US20110245444 Transformation of biomass
10/06/2011	US20110245259 5-Amino-2-(1-Hydroxy-Ethyl)-Tetrahydropyran Derivatives
10/06/2011	US20110245244 Phenoxy acetic acids as ppar delta activators
10/06/2011	US20110244486 Methods and compositions for the diagnosis and treatment of diabetes
10/06/2011	US20110244481 Coelenterazine analogues and coelenteramide analogues
10/06/2011	US20110243865 Melanin production inhibitor
10/05/2011	EP2297118B1 N- (1, 1, 1, 3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) benzyl-n' -arylcarbonylpiperaz ine derivatives as lxr modulators
10/05/2011	CN102206189A Method for preparing phenazine compound by catalyzing o-halogeno aniline in water phase
10/05/2011	CN102206188A Preparation method for N-(pyrazine-2-yl carbonyl)-L-phenylalanine
10/05/2011	CN102206180A Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
10/05/2011	CN101914070B Synthesis method of henazine-2,3-diamine hydrochloride
10/04/2011	US8030495 Cyclopropyl pyrrolidine orexin receptor antagonists
10/04/2011	US8030488 Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agents
10/04/2011	US8030486 Succinic acid diester derivative, process for production thereof, and use of the derivative in the production of pharmaceutical preparation
10/04/2011	US8030315 DPP-IV inhibitor including beta-amino group, preparation method thereof and pharmaceutical composition containing the same for preventing and treating diabetes or obesity
10/04/2011	US8030308 Bicyclic sulfonamide derivatives which are L-CPT 1 inhibitors
10/04/2011	CA2631854C Photochromic indeno-fused naphthopyrans
10/04/2011	CA2491079C Therapeutic piperazine derivatives useful for treating pain
09/2011
09/29/2011	WO2011118672A1 Plasma kallikrein inhibitor
09/29/2011	WO2011117830A1 Derivatives of phenazine useful to treat cancer
09/29/2011	US20110237584 Kynurenine production inhibitor
09/29/2011	US20110236313 Human salty taste receptor and methods of modulating salty taste perception
09/29/2011	US20110232870 Nitrogen-containing fluoroketones for high temperature heat transfer
09/28/2011	EP2368885A1 Derivatives of phenazine useful to treat cancer
09/28/2011	CN102203213A Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/28/2011	CN102203076A Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/28/2011	CN102203065A Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists
09/28/2011	CN102198137A Application of ligustrazine derivant in preparing medicine for treating hepatic fibrosis
09/27/2011	US8026371 Hydroxamates as therapeutic agents
09/27/2011	US8026363 Process for producing coelenteramide or an analog thereof
09/27/2011	US8026239 Cell differentiation inducer
09/27/2011	CA2457410C Compounds effecting glucokinase
09/27/2011	CA2415847C Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
09/22/2011	WO2011113894A1 Pyridine and pyrazine derivative for the treatment of cf
09/22/2011	US20110230492 7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
09/22/2011	US20110230491 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
09/22/2011	US20110230483 Pyridine and Pyrazine derivative for the Treatment of CF
09/22/2011	US20110230446 Cathepsin cysteine protease inhibitors
09/22/2011	CA2793392A1 Pyridine and pyrazine derivative for the treatment of cf
09/21/2011	EP1675835B1 Methods of preparation of dehydro-diketopiperazines in liquid phase or on solid supported phase
09/21/2011	CN102190630A Method for synthesizing 5-methylpyrazine-2-carboxylic acid
09/21/2011	CN101454295B Anti-foot-and-mouth disease virus agent for animal belonging to family suidae or sheep
09/20/2011	US8022210 3-Aminopyrazine-2-carbonylguanidine derivatives; (4-{4-[N'-(3,5-Diamino-6-chloropyrazine-2-carbonyl)guanidino]butyl}phenoxy)acetic acid 2-piperidin-1-yl-ethyl ester; hydration of mucous membranes; respiratory system and gastrointestinal disorders; skin, eye and vaginal dryness; hypotensive agents; asthma
09/15/2011	WO2011111930A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/15/2011	US20110224433 Process for Manufacturing Substituted 3-pyridylmethyl Ammonium Bromides
09/15/2011	US20110224218 Method for inhibiting growth of cancer cells and cell telomere and diseases of cell proliferation by using heteroannelated anthraquinone derivative compounds
09/15/2011	US20110224202 Pde10 inhibitors and related compositions and methods
09/15/2011	US20110224189 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
09/15/2011	US20110224156 Propionic Acids, Propionic Acid Esters, and Related Compounds
09/15/2011	US20110223132 Isothiazoloquinolones and related compounds as anti-infective agents
09/15/2011	US20110223093 Ionic liquid systems for carbon dioxide and sulfur dioxide removal
09/14/2011	EP2365735A2 Luminescent element material and luminescent element comprising the same
09/14/2011	EP2364974A1 N-(3-Phenylamino-quinoxalin-2-yl)-benzenesulfonamide derivatives as phosphatidylinositol 3-kinase inhibitors
09/14/2011	EP2364082A1 Naphthamides as anticancer agents
09/14/2011	EP1871374B1 2,3 substituted pyrazine sulfonamides as inhibitors of crth2

1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 187